Related Experiment Videos

[Subcutaneous panniculitis-like T-cell lymphoma following treatment with rituximab and cyclophosphamide]

J-L Schmutz1, P Trechot

  • 1Service de dermatologie, hôpitaux de Brabois, 6, rue du Morvan, 54511 Vandoeuvre-Lès-Nancy, France. jl.schmutz@chu-nancy.fr

Annales De Dermatologie Et De Venereologie
|March 8, 2013
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...